BRCA testing and testing results among women 18–65 years old

Since the 1990 s discovery of BRCA1 and BRCA2 pathogenic variants in breast or ovarian cancer patients, genetic testing has been recommended as part of a targeted, individualized approach for cancer prevention and treatment in eligible individuals. The aim of this study was to assess trends in BRCA...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Fangjian, Scholl, Matthew, Fuchs, Erika L., Berenson, Abbey B., Kuo, Yong-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866899/
https://www.ncbi.nlm.nih.gov/pubmed/35242503
http://dx.doi.org/10.1016/j.pmedr.2022.101738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866899/
https://www.ncbi.nlm.nih.gov/pubmed/35242503
http://dx.doi.org/10.1016/j.pmedr.2022.101738

Ejemplares similares